Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregg B Fields

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Biopolymers|July 23, 2014
Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and βFranck Madoux, Claudia Tredup, Timothy P Spicer, et al.
Biopolymers|March 11, 2015
Solid-phase synthesis, characterization, and cellular activities of collagen-model nanodiamond-peptide conjugatesAnna M Knapinska, Dorota Tokmina-Roszyk, Sabrina Amar, et al.
Structure (London, England : 1993)|February 5, 2015
Transient collagen triple helix binding to a key metalloproteinase in invasion and developmentYingchu Zhao, Thomas C Marcink, Raghavendar Reddy Sanganna Gari, et al.
The Journal of Biological Chemistry|June 6, 2003
Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassemblyShawn M Sweeney, Gloria DiLullo, Simon J Slater, et al.
Plos One|April 15, 2014
A PCNA-derived cell permeable peptide selectively inhibits neuroblastoma cell growthLong Gu, Shanna Smith, Caroline Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2022
Development of a putative Zn<sup>2+</sup>-chelating but highly selective MMP-13 inhibitorRita Fuerst, Jun Yong Choi, Anna M Knapinska, et al.
Journal of Medicinal Chemistry|June 28, 2017
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 InhibitorsJun Yong Choi, Rita Fuerst, Anna M Knapinska, et al.
The Journal of Biological Chemistry|September 13, 2013
Examination of matrix metalloproteinase-1 in solution: a preference for the pre-collagenolysis stateLinda Cerofolini, Gregg B Fields, Marco Fragai, et al.
Journal of Medicinal Chemistry|October 21, 2014
Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitroTimothy P Spicer, Jianwen Jiang, Alexander B Taylor, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 6, 2025
Matrix metalloproteinase 13 (MMP-13) processing of type II collagen is altered by antibodies and citrullination found in the early stages of rheumatoid arthritisAnna M Knapinska, Dorota Tokmina-Roszyk, Sabrina Haag, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Biopolymers|July 23, 2014
Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and βFranck Madoux, Claudia Tredup, Timothy P Spicer, et al.
Biopolymers|March 11, 2015
Solid-phase synthesis, characterization, and cellular activities of collagen-model nanodiamond-peptide conjugatesAnna M Knapinska, Dorota Tokmina-Roszyk, Sabrina Amar, et al.
Structure (London, England : 1993)|February 5, 2015
Transient collagen triple helix binding to a key metalloproteinase in invasion and developmentYingchu Zhao, Thomas C Marcink, Raghavendar Reddy Sanganna Gari, et al.
The Journal of Biological Chemistry|June 6, 2003
Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassemblyShawn M Sweeney, Gloria DiLullo, Simon J Slater, et al.
Plos One|April 15, 2014
A PCNA-derived cell permeable peptide selectively inhibits neuroblastoma cell growthLong Gu, Shanna Smith, Caroline Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2022
Development of a putative Zn<sup>2+</sup>-chelating but highly selective MMP-13 inhibitorRita Fuerst, Jun Yong Choi, Anna M Knapinska, et al.
Journal of Medicinal Chemistry|June 28, 2017
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 InhibitorsJun Yong Choi, Rita Fuerst, Anna M Knapinska, et al.
The Journal of Biological Chemistry|September 13, 2013
Examination of matrix metalloproteinase-1 in solution: a preference for the pre-collagenolysis stateLinda Cerofolini, Gregg B Fields, Marco Fragai, et al.
Journal of Medicinal Chemistry|October 21, 2014
Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitroTimothy P Spicer, Jianwen Jiang, Alexander B Taylor, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 6, 2025
Matrix metalloproteinase 13 (MMP-13) processing of type II collagen is altered by antibodies and citrullination found in the early stages of rheumatoid arthritisAnna M Knapinska, Dorota Tokmina-Roszyk, Sabrina Haag, et al.
Pageof 17